Hussain MH - Search Results

1

Oral etoposide in the treatment of hormone-refractory prostate cancer.

Hussain MH, Pienta KJ, Redman BG, Cummings GD, Flaherty LE. Hussain MH, et al. Cancer. 1994 Jul 1;74(1):100-3. doi: 10.1002/1097-0142(19940701)74:1<100::aid-cncr2820740118>3.0.co;2-k. Cancer. 1994. PMID: 8004566

2

Flow cytometric DNA analysis of fresh prostatic resections. Correlation with conventional prognostic parameters in patients with prostate cancer.

Hussain MH, Powell I, Zaki N, Maciorowski Z, Sakr W, KuKuruga M, Visscher D, Haas GP, Pontes JE, Ensley JF. Hussain MH, et al. Cancer. 1993 Nov 15;72(10):3012-9. doi: 10.1002/1097-0142(19931115)72:10<3012::aid-cncr2820721025>3.0.co;2-y. Cancer. 1993. PMID: 7693326

3

Future directions in prostate cancer treatment: an oncologist's perspective.

Hussain M. Hussain M. Prostate Suppl. 1996;6:26-30. Prostate Suppl. 1996. PMID: 8630225 Review.

4

Southwest Oncology Group studies in hormone-refractory prostate cancer.

Hussain MH, Blumenstein B, Eisenberger M, Crawford ED. Hussain MH, et al. Semin Oncol. 1996 Dec;23(6 Suppl 14):24-7. Semin Oncol. 1996. PMID: 8996581 Review.

5

Prostate Cancer - Old Problems and New Approaches. (Part II. Diagnostic and Prognostic Markers, Pathology and Biological Aspects).

Honn KV, Aref A, Chen YQ, Cher ML, Crissman JD, Forman JD, Gao X, Grignon D, Hussain M, Porter AT, Pontes EJ, Powell I I, Redman B, Sakr W, Severson R, Tang DG, Wood DP Jr. Honn KV, et al. Pathol Oncol Res. 1996;2(3):191-211. doi: 10.1007/BF02903527. Pathol Oncol Res. 1996. PMID: 11173606 Free article.

6

Prostate Cancer Old Problems and New Approaches. Part III. Prevention and Treatment.

Honn KV, Aref A, Chen YQ, Cher ML, Crissman JD, Forman JD, Gao X, Grignon D, Hussain M, Porter AT, Pontes JE, Powell I I, Redman B, Sakr W, Severson R, Tang DG, Wood DP Jr. Honn KV, et al. Pathol Oncol Res. 1996;2(4):276-292. doi: 10.1007/BF02904824. Pathol Oncol Res. 1996. PMID: 11173616 Free article.

7

A phase II trial of estramustine and etoposide in hormone refractory prostate cancer: A Southwest Oncology Group trial (SWOG 9407).

Pienta KJ, Fisher EI, Eisenberger MA, Mills GM, Goodwin JW, Jones JA, Dakhil SR, Crawford ED, Hussain MH. Pienta KJ, et al. Among authors: hussain mh. Prostate. 2001 Mar 1;46(4):257-61. doi: 10.1002/1097-0045(20010301)46:4<257::aid-pros1031>3.0.co;2-4. Prostate. 2001. PMID: 11241547 Free article. Clinical Trial.

8

Couples' experiences with prostate cancer: focus group research.

Harden J, Schafenacker A, Northouse L, Mood D, Smith D, Pienta K, Hussain M, Baranowski K. Harden J, et al. Oncol Nurs Forum. 2002 May;29(4):701-9. doi: 10.1188/02.ONF.701-709. Oncol Nurs Forum. 2002. PMID: 12011916

9

An active regimen of weekly paclitaxel and estramustine in metastatic androgen-independent prostate cancer.

Vaishampayan U, Fontana J, Du W, Hussain M. Vaishampayan U, et al. Urology. 2002 Dec;60(6):1050-4. doi: 10.1016/s0090-4295(02)01990-8. Urology. 2002. PMID: 12475668 Clinical Trial.

10

A phase II study of rebeccamycin analog (NSC-655649) in metastatic renal cell cancer.

Hussain M, Vaishampayan U, Heilbrun LK, Jain V, LoRusso PM, Ivy P, Flaherty L. Hussain M, et al. Invest New Drugs. 2003 Nov;21(4):465-71. doi: 10.1023/a:1026259503954. Invest New Drugs. 2003. PMID: 14586215 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

323 results

Search Page

Filters